H Padma-Nathan

Summary

Affiliation: The Male Clinic
Country: USA

Publications

  1. ncbi request reprint Efficacy and tolerability of tadalafil, a novel phosphodiesterase 5 inhibitor, in treatment of erectile dysfunction
    Harin Padma-Nathan
    Male Clinic, Beverly Hills, California, USA
    Am J Cardiol 92:19M-25M. 2003
  2. ncbi request reprint Erectile dysfunction secondary to nerve-sparing radical retropubic prostatectomy: comparative phosphodiesterase-5 inhibitor efficacy for therapy and novel prevention strategies
    Harin Padma-Nathan
    Male Clinic, Beverly Hills, CA 90210, USA
    Curr Urol Rep 5:467-71. 2004
  3. ncbi request reprint Pharmacotherapy for erectile dysfunction
    Harin Padma-Nathan
    J Sex Med 1:128-40. 2004
  4. ncbi request reprint A 4-year update on the safety of sildenafil citrate (Viagra)
    Harin Padma-Nathan
    The Male Clinic, Keck School of Medicine at the University of Southern California School of Medicine, Beverly Hills, California, USA
    Urology 60:67-90. 2002
  5. ncbi request reprint Introduction. The management of erectile dysfunction (ED)
    Harin Padma-Nathan
    The Male Clinic, the Keck School of Medicine at the University of Southern California School of Medicine, Beverly Hills, California, USA
    Urology 60:1-3. 2002
  6. ncbi request reprint Sildenafil citrate (Viagra) treatment for erectile dysfunction: An updated profile of response and effectiveness
    H Padma-Nathan
    Clinical Professor of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Int J Impot Res 18:423-31. 2006
  7. ncbi request reprint An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients
    Harin Padma-Nathan
    The Keck School of Medicine of the University of Southern California, The Male Clinic, Beverly Hills, California 90212, USA
    Urology 68:386-91. 2006
  8. ncbi request reprint Oral drug therapy for erectile dysfunction
    H Padma-Nathan
    Department of Urology, Keck School of Medicine, University of Southern California Beverly Hills, California, USA
    Urol Clin North Am 28:321-34. 2001
  9. ncbi request reprint Erectile dysfunction in patients with coronary artery disease
    R Kloner
    Heart Institute, Good Samaritan Hospital USC, Los Angeles, CA 90017, USA
    Int J Impot Res 17:209-15. 2005
  10. doi request reprint Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy
    H Padma-Nathan
    Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Int J Impot Res 20:479-86. 2008

Detail Information

Publications31

  1. ncbi request reprint Efficacy and tolerability of tadalafil, a novel phosphodiesterase 5 inhibitor, in treatment of erectile dysfunction
    Harin Padma-Nathan
    Male Clinic, Beverly Hills, California, USA
    Am J Cardiol 92:19M-25M. 2003
    ..Headache and dyspepsia have been most frequently reported. Changes in color vision have been rare (<0.1%) with tadalafil across all clinical trials. Tadalafil appears to be a safe and effective treatment for men with ED...
  2. ncbi request reprint Erectile dysfunction secondary to nerve-sparing radical retropubic prostatectomy: comparative phosphodiesterase-5 inhibitor efficacy for therapy and novel prevention strategies
    Harin Padma-Nathan
    Male Clinic, Beverly Hills, CA 90210, USA
    Curr Urol Rep 5:467-71. 2004
    ..In primary prevention, unlike ED therapy, one has only "one shot" by definition. Therefore, it is even more critical to apply evidence-based medicine...
  3. ncbi request reprint Pharmacotherapy for erectile dysfunction
    Harin Padma-Nathan
    J Sex Med 1:128-40. 2004
    ..Advances in understanding of the biochemistry and physiology of penile erection have led to breakthroughs in pharmacotherapy of erectile dysfunction...
  4. ncbi request reprint A 4-year update on the safety of sildenafil citrate (Viagra)
    Harin Padma-Nathan
    The Male Clinic, Keck School of Medicine at the University of Southern California School of Medicine, Beverly Hills, California, USA
    Urology 60:67-90. 2002
    ..Lastly, we review the specific effects on the visual system based on findings from studies conducted during drug development and post marketing...
  5. ncbi request reprint Introduction. The management of erectile dysfunction (ED)
    Harin Padma-Nathan
    The Male Clinic, the Keck School of Medicine at the University of Southern California School of Medicine, Beverly Hills, California, USA
    Urology 60:1-3. 2002
  6. ncbi request reprint Sildenafil citrate (Viagra) treatment for erectile dysfunction: An updated profile of response and effectiveness
    H Padma-Nathan
    Clinical Professor of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Int J Impot Res 18:423-31. 2006
    ..Increased understanding of the sildenafil response and effectiveness profiles and optimal sildenafil treatment are central to the appropriate management of erectile dysfunction using sildenafil...
  7. ncbi request reprint An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients
    Harin Padma-Nathan
    The Keck School of Medicine of the University of Southern California, The Male Clinic, Beverly Hills, California 90212, USA
    Urology 68:386-91. 2006
    ..To assess the safety and efficacy of topical alprostadil cream for erectile dysfunction (ED)...
  8. ncbi request reprint Oral drug therapy for erectile dysfunction
    H Padma-Nathan
    Department of Urology, Keck School of Medicine, University of Southern California Beverly Hills, California, USA
    Urol Clin North Am 28:321-34. 2001
    ..The future is bright for this infant field of sexual pharmacotherapy...
  9. ncbi request reprint Erectile dysfunction in patients with coronary artery disease
    R Kloner
    Heart Institute, Good Samaritan Hospital USC, Los Angeles, CA 90017, USA
    Int J Impot Res 17:209-15. 2005
    ..The Princeton Consensus Guidelines (soon to be updated) suggest a logical approach to the patient with CAD seeking therapy for sexual dysfunction...
  10. doi request reprint Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy
    H Padma-Nathan
    Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Int J Impot Res 20:479-86. 2008
    ..0156, Fisher's exact test) of the sildenafil group. Nightly sildenafil administration for 36 weeks after surgery markedly increased the return of normal spontaneous erections...
  11. ncbi request reprint On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction
    H Padma-Nathan
    Keck School of Medicine, University of Southern California, Los Angeles, California 90212, USA
    Int J Impot Res 13:2-9. 2001
    ..The most common adverse events were headache and dyspepsia. The conclusion of this study was that on-demand IC351 at doses up to 25 mg was well tolerated and significantly improved erectile function...
  12. ncbi request reprint The efficacy and safety of a topical alprostadil cream, Alprox-TD, for the treatment of erectile dysfunction: two phase 2 studies in mild-to-moderate and severe ED
    H Padma-Nathan
    The Male Clinic, Beverly Hills, CA, USA
    Int J Impot Res 15:10-7. 2003
    ..Topical alprostadil was well tolerated with the most common adverse event being urogenital pain. These results suggest this topical alprostadil formulation may be a potentially useful agent for the treatment of ED...
  13. ncbi request reprint Minimal time to successful intercourse after sildenafil citrate: results of a randomized, double-blind, placebo-controlled trial
    H Padma-Nathan
    Department of Urology, University of Southern California Keck School of Medicine, Los Angeles, California, USA
    Urology 62:400-3. 2003
    ..To determine the minimal time to successful intercourse after taking sildenafil citrate for erectile dysfunction (ED)...
  14. ncbi request reprint Erectile dysfunction in the cardiac patient: how common and should we treat?
    Robert A Kloner
    Heart Institute, Good Samaritan Hospital, 1225 Wilshire Blvd, Los Angeles, California 90017, USA
    J Urol 170:S46-50; discussion S50. 2003
    ..However, most cardiologists do not routinely ask about ED and patients often are reluctant or embarrassed to discuss it. We determined how common ED was in a group of patients with chronic stable coronary artery disease...
  15. ncbi request reprint Vardenafil restores erectile function to normal range in men with erectile dysfunction
    Harin Padma-Nathan
    Male Clinic, Beverly Hills, CA 90212, USA
    J Sex Med 4:152-61. 2007
    ..The ability of oral phosphodiesterase type 5 (PDE5) inhibitor therapy to restore erectile function to normal is an important attribute to men with erectile dysfunction (ED)...
  16. ncbi request reprint Efficacy and safety of pomegranate juice on improvement of erectile dysfunction in male patients with mild to moderate erectile dysfunction: a randomized, placebo-controlled, double-blind, crossover study
    C P Forest
    The Male Clinic, Beverly Hills, CA, USA
    Int J Impot Res 19:564-7. 2007
    ..058). Although overall statistical significance was not achieved, this pilot study suggests the possibility that larger cohorts and longer treatment periods may achieve statistical significance...
  17. ncbi request reprint Summary of the recommendations on sexual dysfunctions in men
    Tom F Lue
    Department of Urology, UCSF, San Francisco, CA, USA
    J Sex Med 1:6-23. 2004
    ..Disorders of sexual function in men include erectile dysfunction, orgasm/ejaculation disorders, priapism, and Peyronie's disease...
  18. ncbi request reprint Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trial
    Andrew R McCullough
    New York University Medical Center Urology, New York, NY, USA
    J Sex Med 5:476-84. 2008
    ..After bilateral nerve-sparing radical retropubic prostatectomy (BNSRRP), nocturnal and sexually mediated erections may help to preserve normal erectile function (EF)...
  19. ncbi request reprint Oral sildenafil in the treatment of erectile dysfunction. 1998
    Irwin Goldstein
    J Urol 167:1197-203; discussion 1204. 2002
  20. ncbi request reprint Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial
    Wayne J G Hellstrom
    Department of Urology, Tulane University Medical Center, New Orleans, Louisiana 70112, USA
    J Androl 23:763-71. 2002
  21. ncbi request reprint Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra)
    Francesco Montorsi
    Department of Urology, Universita Vita e Salute San Raffaele, Milan, Italy
    Urology 68:26-37. 2006
    ....
  22. ncbi request reprint Determining the earliest time within 30 minutes to erectogenic effect after tadalafil 10 and 20 mg: a multicenter, randomized, double-blind, placebo-controlled, at-home study
    Raymond C Rosen
    Robert Wood Johnson Medical School, Piscataway, NJ, USA
    J Sex Med 1:193-200. 2004
    ..Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor used for the treatment of erectile dysfunction (ED). The minimal time to onset of erectogenic effect in the at-home setting has not been evaluated...
  23. ncbi request reprint Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: a randomized, double-blind, placebo-controlled trial
    Francesco Montorsi
    Department of Urology, Universita Vita Salute San Raffaele, Milan, Italy
    J Sex Med 1:168-78. 2004
    ..Of considerable interest to patients and physicians is an understanding of the time required after dosing to attain penile erection sufficient for successful sexual intercourse...
  24. ncbi request reprint Topical alprostadil cream for the treatment of erectile dysfunction: a combined analysis of the phase II program
    Christopher Steidle
    Northeast Indiana Research, Fort Wayne, Indiana, USA
    Urology 60:1077-82. 2002
    ..To present a meta-analysis of the efficacy and safety data of two recently completed Phase II studies examining a novel alprostadil topical cream for the treatment of erectile dysfunction (ED)...
  25. ncbi request reprint Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial
    Wayne J G Hellstrom
    Department of Urology, Tulane University Medical Center, New Orleans, Louisiana 70112, USA
    Urology 61:8-14. 2003
    ..Vardenafil was well tolerated. These results demonstrate that vardenafil provides sustained efficacy with reduced incidence of nuisance side effects over time. High resolution video, medium resolution video, low resolution video...
  26. ncbi request reprint Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial
    Hartmut Porst
    Private Urological Practice, Hamburg, Germany
    Urology 62:121-5; discussion 125-6. 2003
    ..To examine the therapeutic effects of tadalafil on erectile dysfunction (ED) at 24 and 36 hours after dosing...
  27. ncbi request reprint Efficacy and safety of topical alprostadil cream for the treatment of female sexual arousal disorder (FSAD): a double-blind, multicenter, randomized, and placebo-controlled clinical trial
    Harin Padma-Nathan
    The Male Clinic, Beverly Hills, California, USA
    J Sex Marital Ther 29:329-44. 2003
    ..157; 1500 g versus placebo). Adverse events were generally mild or moderate in intensity and mainly involved localized reactions in the genital area...
  28. ncbi request reprint Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy
    Gerald Brock
    St Joseph s Medical Center, Lawson Research Institute, London, Ontario, Canada
    J Urol 170:1278-83. 2003
    ..The efficacy and safety of vardenafil, a potent, selective, phosphodiesterase 5 inhibitor, was assessed for the treatment of ED after radical prostatectomy...
  29. ncbi request reprint Roundtable discussion: tadalafil study group
    Robert A Kloner
    Division of Cardiovascular Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA
    Am J Cardiol 92:58M-65M. 2003
  30. ncbi request reprint Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel
    Kevin L Billups
    The EpiCenter for Sexual Health and Medicine, University of Minnesota School of Medicine, Minneapolis, USA
    J Sex Med 2:40-50; discussion 50-2. 2005
    ..The prevalence of cardiovascular disease is increasing worldwide, which underscores the urgency to improve methods of prevention and early detection...
  31. doi request reprint Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder
    Eric S Rovner
    Department of Urology, Medical University of South Carolina, 96 Jonathan Lucas St, CSB 644, Charleston, SC 29425, USA
    Urology 72:488-93. 2008
    ..To assess efficacy and tolerability of tolterodine extended release (ER) in continent and incontinent subjects with overactive bladder (OAB)...